Literature DB >> 9042918

Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27.

H Matsumine1, M Saito, S Shimoda-Matsubayashi, H Tanaka, A Ishikawa, Y Nakagawa-Hattori, M Yokochi, T Kobayashi, S Igarashi, H Takano, K Sanpei, R Koike, H Mori, T Kondo, Y Mizutani, A A Schäffer, Y Yamamura, S Nakamura, S Kuzuhara, S Tsuji, Y Mizuno.   

Abstract

An autosomal recessive form of juvenile Parkinsonism (AR-JP) (MIM 600116) is a levodopa-responsive Parkinsonism whose pathological finding is a highly selective degeneration of dopaminergic neurons in the zona compacta of the substantia nigra. By linkage analysis of diallelic polymorphism of the Mn-superoxide dismutase gene (SOD2), we found a family with AR-JP showing perfect segregation of the disease with the SOD2 locus. By extending the linkage analysis to 13 families with AR-JP, we discovered strong evidence for the localization of the AR-JP gene at chromosome 6q25.2-27, including the SOD2 locus, with the maximal cumulative pairwise LOD scores of 7.26 and 7.71 at D6S305 (theta = .03) and D6S253 (theta = .02), respectively. Observation of obligate recombination events, as well as multipoint linkage analysis, placed the AR-JP gene in a 17-cM interval between D6S437 and D6S264. Delineation of the AR-JP gene will be an important step toward our understanding of the molecular mechanism underlying selective degeneration of the nigral neurons.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9042918      PMCID: PMC1712507     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  27 in total

1.  Purification of DNA from formaldehyde fixed and paraffin embedded human tissue.

Authors:  S E Goelz; S R Hamilton; B Vogelstein
Journal:  Biochem Biophys Res Commun       Date:  1985-07-16       Impact factor: 3.575

2.  Human Mn superoxide dismutase cDNA sequence.

Authors:  Y Beck; R Oren; B Amit; A Levanon; M Gorecki; J R Hartman
Journal:  Nucleic Acids Res       Date:  1987-11-11       Impact factor: 16.971

3.  Isolation of cDNAs encoding human manganese superoxide dismutase.

Authors:  K Heckl
Journal:  Nucleic Acids Res       Date:  1988-07-11       Impact factor: 16.971

4.  Paralysis agitans of early onset with marked diurnal fluctuation of symptoms.

Authors:  Y Yamamura; I Sobue; K Ando; M Iida; T Yanagi
Journal:  Neurology       Date:  1973-03       Impact factor: 9.910

5.  Easy calculations of lod scores and genetic risks on small computers.

Authors:  G M Lathrop; J M Lalouel
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

6.  Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism.

Authors:  A Ishikawa; S Tsuji
Journal:  Neurology       Date:  1996-07       Impact factor: 9.910

7.  Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity by 1-methyl-4-phenylpyridinium ion.

Authors:  Y Mizuno; T Saitoh; N Sone
Journal:  Biochem Biophys Res Commun       Date:  1987-02-27       Impact factor: 3.575

8.  Multilocus linkage analysis in humans: detection of linkage and estimation of recombination.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Am J Hum Genet       Date:  1985-05       Impact factor: 11.025

9.  A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra.

Authors:  H Saggu; J Cooksey; D Dexter; F R Wells; A Lees; P Jenner; C D Marsden
Journal:  J Neurochem       Date:  1989-09       Impact factor: 5.372

Review 10.  Biosynthesis and regulation of superoxide dismutases.

Authors:  H M Hassan
Journal:  Free Radic Biol Med       Date:  1988       Impact factor: 7.376

View more
  93 in total

Review 1.  Rare genetic mutations shed light on the pathogenesis of Parkinson disease.

Authors:  Ted M Dawson; Valina L Dawson
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 2.  The genetic basis of Parkinson's disease.

Authors:  T Foltynie; S Sawcer; C Brayne; R A Barker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

3.  Genome-wide scan linkage analysis for Parkinson's disease: the European genetic study of Parkinson's disease.

Authors:  M Martinez; A Brice; J R Vaughan; A Zimprich; M M B Breteler; G Meco; A Filla; M J Farrer; C Bétard; J Hardy; G De Michele; V Bonifati; B Oostra; T Gasser; N W Wood; A Dürr
Journal:  J Med Genet       Date:  2004-12       Impact factor: 6.318

4.  ParkScreen: a low-cost rapid linkage marker panel for Parkinson's disease.

Authors:  Alessandro De Grandi; Claudia Béu Volpato; Elisa Bedin; Cristian Pattaro; Fabio Marroni; Irene Pichler; Andrew Antony Hicks; Giorgio Casari; Peter Paul Pramstaller
Journal:  J Mol Neurosci       Date:  2009-03-25       Impact factor: 3.444

Review 5.  Shedding light on mitophagy in neurons: what is the evidence for PINK1/Parkin mitophagy in vivo?

Authors:  Nadia Cummins; Jürgen Götz
Journal:  Cell Mol Life Sci       Date:  2017-10-30       Impact factor: 9.261

6.  Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression.

Authors:  Juan Liu; Cen Zhang; Hao Wu; Xiao-Xin Sun; Yanchen Li; Shan Huang; Xuetian Yue; Shou-En Lu; Zhiyuan Shen; Xiaoyang Su; Eileen White; Bruce G Haffty; Wenwei Hu; Zhaohui Feng
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

Review 7.  The genetics of Parkinson's disease.

Authors:  Kah Leong Lim; Valina L Dawson; Ted M Dawson
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

8.  Nonsynonymous polymorphisms of histamine-metabolising enzymes in patients with Parkinson's disease.

Authors:  José A G Agúndez; Antonio Luengo; Oscar Herráez; Carmen Martínez; Hortensia Alonso-Navarro; Félix Javier Jiménez-Jiménez; Elena García-Martín
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

Review 9.  α-Synuclein oligomers and clinical implications for Parkinson disease.

Authors:  Lorraine V Kalia; Suneil K Kalia; Pamela J McLean; Andres M Lozano; Anthony E Lang
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

Review 10.  Targeting Pink1-Parkin-mediated mitophagy for treating liver injury.

Authors:  Jessica A Williams; Wen-Xing Ding
Journal:  Pharmacol Res       Date:  2015-10-24       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.